18-Methoxycoronaridine (18-MC)

18-Methoxycoronadine is a derivative of ibogaine. The compound was invented in 1996 by a combination of researchers and chemists from the University of Vermont. 18-Methoxycoronaridine has been studied at length in clinical trials and has been found to reduce nicotine and alcohol intake in rats. The drug is being further studied for the potential treatment of alcohol and nicotine addiction in humans.